These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7539635)

  • 21. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
    Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
    Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy.
    Corrigan CJ; Haczku A; Gemou-Engesaeth V; Doi S; Kikuchi Y; Takatsu K; Durham SR; Kay AB
    Am Rev Respir Dis; 1993 Mar; 147(3):540-7. PubMed ID: 8095124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures.
    Thomson AW; Woo J; Yao GZ; Todo S; Starzl TE; Zeevi A
    Transpl Immunol; 1993; 1(2):146-50. PubMed ID: 7521738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.
    Marinaki S; Neumann I; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt W; Waldherr R; Yard BA; Van Der Woude FJ
    Clin Exp Immunol; 2005 Apr; 140(1):181-91. PubMed ID: 15762890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy-induced expansion of regulatory T-lymphocytes may mediate protection to multiple sclerosis activity.
    Sánchez-Ramón S; Navarro A J; Aristimuño C; Rodríguez-Mahou M; Bellón JM; Fernández-Cruz E; de Andrés C
    Immunol Lett; 2005 Jan; 96(2):195-201. PubMed ID: 15585323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
    Adamthwaite D; Cooley MA
    Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
    Chung Y; Lee SH; Kim DH; Kang CY
    J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
    Gladstone DE; Golightly MG; Brannagan TH
    J Neuroimmunol; 2007 Oct; 190(1-2):121-6. PubMed ID: 17854912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
    Chu ZQ; Ji Q
    Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.
    Cantó E; Rodriguez-Sanchez JL; Vidal S
    J Leukoc Biol; 2003 Dec; 74(6):998-1007. PubMed ID: 12972509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Sasaki M; Obata H; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Jun; 9(3):270-6. PubMed ID: 15967005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose methylprednisolone treatment-induced changes in immunological parameters in progressive MS patients.
    Dufour A; Salmaggi A; La Mantia L; Eoli M; Nespolo A; Milanese C
    Int J Neurosci; 1994 Mar; 75(1-2):119-28. PubMed ID: 7914185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.
    Thomson AW; Carroll PB; McCauley J; Woo J; Abu-Elmagd K; Starzl TE; Van Thiel DH
    Springer Semin Immunopathol; 1993; 14(4):323-44. PubMed ID: 7686690
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis.
    Hafler DA; Orav J; Gertz R; Stazzone L; Weiner HL
    J Neuroimmunol; 1991 May; 32(2):149-58. PubMed ID: 1672870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.